Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 1Hypotrichosis 1

Interventions

Proflavine 9Microbial Collagenase 2plerixafor 1pembrolizumab 1pegfilgrastim 1olaparib 1nilotinib 1macimorelin 1keyhole-limpet hemocyanin 1ethyl pyruvate 1compound W 1blinatumomab 1Uracil 1Tegafur 1Surgical Procedures, Operative 1Sodium Chloride 1Sirolimus 1Salicylates 1Peptides 1PM 01183 1Monatide (IMS 3015) 1Mifepristone 1Gemcitabine 1Fluorescein 1Everolimus 1Doxorubicin 1Darbepoetin alfa 1Curettage 1Corlux 1Circumcision, Male 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDIV × Interventional × Bimatoprost × Clear all
NCT01387906 2012-06-15

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Beer, Kenneth R., M.D., PA

Phase 4 Completed
20 enrolled
Lymphoid

Hypotrichosis, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡